The effects of micronutrient supplementation on vasomotor symptoms in postmenopausal women

Climacteric

Volumn 14, Issue 5, 2011, Pages 544-550

  Andrikoula, M ^a   Baker, D ^b   Nesic, J ^c   Liao, L M ^b   Duka, T ^d   Prelevic, G M ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

^b CAMDEN AND ISLINGTON NHS FOUNDATION TRUST   (United Kingdom)

^c UNIVERSITY OF BRIGHTON   (United Kingdom)

^d UNIVERSITY OF SUSSEX   (United Kingdom)

Author keywords

Hot flushes; Menopause; Nutritional supplement

Indexed keywords

4 AMINOBENZOIC ACID; ALPHA TOCOPHEROL; ASCORBIC ACID; BIOTIN; CHROMIUM; COPPER; CYANOCOBALAMIN; FOLIC ACID; IODINE; IRON; MAGNESIUM; MANGANESE; NICOTINAMIDE; PANTOTHENIC ACID; PYRIDOXINE; RETINOL; RIBOFLAVIN; SELENIUM; THIAMINE; TRACE ELEMENT; VITAMIN; VITAMIN D; ZINC;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; FEMALE; HOT FLUSH; HUMAN; MAJOR CLINICAL STUDY; MENOPAUSAL SYNDROME; NIGHT SWEAT; PRIORITY JOURNAL; PROFILE OF MOOD STATES; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; READING; SELF REPORT; VERBAL MEMORY; VITAMIN SUPPLEMENTATION;

ADULT; AGED; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FEMALE; HOT FLASHES; HUMANS; MICRONUTRIENTS; MIDDLE AGED; PLACEBOS; POSTMENOPAUSE; QUESTIONNAIRES; SWEATING;

EID: 80052996028     PISSN: 13697137     EISSN: 14730804     Source Type: Journal    
DOI: 10.3109/13697137.2011.558951     Document Type: Article

References (45)

1. Thompson B, Hart SA, Durno D. Menopausal age and symptomatology in general practice. J Biosoc Sci 1973;5:71-82
2. McKinlay SM, Jeffreys M. The menopausal syndrome. B r J Prev Soc Med 1974;28:108-15
3. Staropoli CA, Flaws JA, Bush TL, Moulton AW. Predictors of menopausal hot fl ashes. J Women s Health 1998;7:1149-55
4. W illiams RE, Kalilani L, Dibenedetti DB, et al. Frequency and severity of vasomotor symptoms among peri- and postmenopausal women in the United States. Climacteric 2008;11:32-43
5. Lock M, Kaufert P, Gilbert P. Cultural construction of the menopausal syndrome: the Japanese case. Maturitas 1988;10:317-32
6. Boulet MJ, Oddens BJ, Lehert P, Verner HM, Visser A. Climacteric and menopause in seven south-east Asian countries. Maturitas 1994;19:205-9
7. Ho SC, Chan SG, Yip YB, Cheng A, Yi Q, Chan C. Menopausal symptoms and symptom clustering in Chinese women. Maturitas 1999;33:219-27
8. Chim H, Tan BH, Ang CC, Chew EM, Chong YS, Saw SM. The prevalence of menopausal symptoms in a community in Singapore. Maturitas 2002;41:275-82
9. Haines CJ, Xing SM, Park KH, Holinka CF, Ausmanas MK. Prevalence of menopausal symptoms in different ethnic groups of Asian women and responsiveness to therapy with three doses of conjugated oestrogens/medroxyprogesterone acetate: the Pan- Asia Menopause (PAM) study. Maturitas 2005;52:264-76
10. Gold EB, Colvin A, Avis N, et al. Longitudinal analysis of the association between vasomotor symptoms and race/ethnicity across the menopausal transition: Study of Women s Health Across the Nation. Am J Publ Health 2006;96:1226-35
11. Freeman EW, Sherif K. Prevalence of hot fl ushes and night sweats around the world: a systematic review. Climacteric 2007;10: 197-214
12. Kronenberg F. Hot fl ashes: epidemiology and physiology. Ann NY Acad Sci 1990;592:52-86
13. Barlow DH, Grosset KA, Hart DM. A study of the experience of Glasgow women in the climacteric years. Br J Obstet Gynaecol 1989;96:1192-7
14. Daly E, Gray A, Barlow D, McPherson K, Roche M, Vessy M. Measuring the impact of menopausal symptoms on quality of life. BMJ 1993;307:836-40
15. Oldenhave A, Netelenbos C. Pathogenesis of climacteric complaints: ready for the change? Lancet 1994;343:649-53
16. Stearns V, Ullmer L, Lopez JF, Smith Y, Isaacs C, Hayes DF. Hot fl ushes. Lancet 2002;360:1851-61
17. Shanafelt TD, Barton DL, Adjei AA, Loprinzi CL. Pathophysiology and treatment of hot fl ashes. Mayo Clin Proc 2002;77: 1207-18
18. Maclennan AH, Broadbent JL, Lester S, Moore V. Oral oestrogen and combined oestrogen/progestogen therapy versus placebo for hot fl ushes. Cochrane Database Syst Rev 2004;(4):CD002978.
19. Nelson HD. Commonly used types of postmenopausal estrogen for treatment of hot fl ashes: scientifi c review. JAMA 2004;291: 1610-20
20. Limouzin-Lamothe MA,Mairon N, Joyce CR, Le Gal M. Quality of life after the menopause: infl uence of hormonal replacement therapy. Am J Obstet Gynecol 1994;170:618-24
21. Grady D, Wenger NK, Herrington D, et al. Postmenopausal hormone therapy increases risk for venous thromboembolic disease. The Heart and Estrogen/progestin Replacement Study. Ann Intern Med 2000;132:689-96
22. Seibel MM. Treating hot fl ushes without hormone replacement therapy. J Fam Pract 2003;52:291-6
23. Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefi ts of estrogen plus progestin in healthy postmenopausal women: principal results fro the Women s Health Initiative randomized controlled trial. JAMA 2002;288:321-33
24. Butt DA, Deng LY, Lewis JE, Lock M. Minimal decrease in hot fl ushes desired by postmenopausal women in family practice. Menopause 2007;14:203-6
25. Nelson HD. Menopause. L ancet 2008;371:760-70
26. MacLennan AH, Gill TK, Broadbent JL, Taylor AW. Continuing decline in hormone therapy use: population trends over 17 years. Climacteric 2009;12:122-30
27. Newton KM, Buist DS, Keenan NL, Anderson LA, LaCroix AZ. Use of alternative therapies for menopause symptoms: results of a population-based survey. Obstet Gynecol 2002;100: 18-25
28. Grady D. Management of menopausal symptoms. N Engl J Med 2006;355:2338-47
29. Moyad MA. Complementary/alternative therapies for reducing hot fl ashes in prostate cancer patients: re-evaluating the existing indirect data from studies of breast cancer and postmenopausal women. Urology 2002;59:20-33
30. Arora R, Sharma JB, Wadhwa L, Batra S, Sharma S. Effi cacy of Menopace (multi vitamins and minerals) in menopausal symptoms: a placebo controlled prospective trial. Obs & Gynae Today 2005;10:115-18
31. Kirby RS. Menopace nutrient therapy. An alternative approach to pharmaceutical treatments for menopause. Int J Fertil 2006;51: 125-9
32. Mehrabian A, Russell JA. A questionnaire measure of habitual alcohol use. Psychol Rep 1978;43:803-6
33. Hunter MS, Liao KLM. A psychological analysis of menopausal hot fl ushes. Br J Clin Psychol 1995;34:589-99
34. McNair D, Lorr M, Droppleman L. P rofi le of Mood States (Manual) . San Diego: Education and Industrial Testing Service, 1971
35. The WHOQoL Group. Development of the World Health Organization WHOQoL-BREF quality of life assessment. Psychol Med 1998;28:551-8
36. Avis NE, Crawford S, Stellato R, Longcope C. Longitudinal study of hormone levels and depression among women transitioning through menopause. Climacteric 2001;4:243-9
37. Joffe H, Hall JE, Soares CN, et al. Vasomotor symptoms are associated with depression in perimenopausal women seeking primary care. Menopause 2002;9:392-8
38. Thurston RC, Blumenthal JA, Babyak MA, Sherwood A. Emotional antecedents of hot fl ushes during daily life. Psychosom Med 2005;67:137-46
39. Freeman EW, Sammel MD, Lin H, Gracia C, Kapoor S, Ferdousi T. The role of anxiety and hormonal changes in menopausal hot fl ashes. Menopause 2005;12:258-66
40. Ginsburg J, Swinhoe J, O Reilly B. Cardiovascular responses during the menopausal hot fl ush. Br J Obstet Gynaecol 1981;88: 925-30
41. Gannon L, Hansel S, Goodwin J. Correlates of menopausal hot fl ushes. J Behav Med 1987;10:277-85
42. Swartzman LC, Edelberg R, Kemmann E. Impact of stress on objectively recorded menopausal hot fl ushes and on fl ush report bias. Health Psychol 1990;9:529-45
43. Stevenson DW, Delprato DJ. Multiple component self control programme for menopausal hot fl ushes. J Behav Ther Exp Psychiatry 1983;14:137-40
44. Hunter MS, Liao KLM. An evaluation of a four-session cognitive behavioural intervention for menopausal hot fl ushes. Br J Health Psychol 1996;1:113-25
45. Irvin JH, Domar AD, Clark C, Zuttermeister PC, Friedman R. The effects of relaxation response training on menopausal symptoms. J Psychosom Obstet Gynaecol 1996;17:202-7